Current Issue: Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study
https://t.co/aFMmhfxyZ1
@WGondoputro@DJReesink@AlexBlazevski@lawrentschuk
Thrilled to announce my labor of love - MedLitGo!
A free mobile site for doctors to get key insights from the latest medical papers easily:
RT to help spread the word!
Sign up: https://t.co/K3mPpBs0dz
Twitter: https://t.co/g8QnTtGBWb
LinkedIn: https://t.co/nN0dz3Oo08
#MedEd
What a fantastic research group @drlouiseemmett @ PhilStricker @jj0001! Some fantastic work on show for diagnostic, localised & advanced prostate Ca. Thank you for inviting me to speak to your team & look forward to some 🇬🇧 🇦🇺 collabs @GarvanInstitute @SVHSydney @kinghorncancer
Fantastic send-off for Foundation Professor of Medicine @uow Prof Wilf Yeo MD FRCP FRACP.
What an incredible legacy of excellence in patient care, research, mentoring and academia. @IllaShoalHealth #Wollongong
Outstanding news!! PSMA PET/CT reimbursement confirmed in Australia for initial staging and biochemical recurrence. All PSMA tracers included. Great day for Australian men with prostate cancer @PCFA@MovemberAUS
Best Scientific Paper 2022:
Louise Emmett et al for their paper, "The Additive Diagnostic Value of Prostate-specific Membrane Antigen PET Computed Tomography to Multiparametric MRI Triage in the Diagnosis of PCa (PRIMARY): A Prospective Multicentre Study"
Congratulations!
Congrats to @drlouiseemmett , Phil Stricker, Will G the team at St Vincent’s & colleagues in the Netherlands who developed the probe design. Initial results from DETECT trial of Tc-PSMA robotic probe to guide ePLND during RARP now available online at JNM https://t.co/fEsFAwy0zj